Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
Fragile X Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Scientific Presentations
Publications
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Apr 28, 2015
Results of Meeting
Apr 28, 2015
Chairman's Address to Shareholders
Apr 22, 2015
Appendix 3B
Apr 21, 2015
Appendix 4C - quarterly
Mar 26, 2015
Appendix 3B
Mar 25, 2015
Notice of Annual General Meeting/Proxy Form
Mar 25, 2015
Annual Report to shareholders
Mar 02, 2015
Neuren receives response to request for Breakthrough Therapy
Feb 25, 2015
Neuren reports 2014 full-year financial results
Feb 25, 2015
Preliminary Final Report and 2014 full year accounts
Previous
1
2
3
4
Next